Infectious Disease established the medical treatment system from October 2012. Currently, my main work is consultation for cases of nosocomial infections, as well as follow-up of patients with positive blood cultures and infection control work. Diagnosis and treatment of common and rare infections are performed, and in close cooperation with General Medicine, we cooperate with all departments in the hospital to support difficult cases of infections and optimal antimicrobial drug treatment. and manage infectious disease patients together.
In addition, as a central acute hospital in Kobe City, our hospital has a class 1 infectious disease bed, and plays a central role in Kobe City even in infectious diseases such as Ebola virus infection, which is a hot topic in health administration. In addition, as an advanced medical institution, we also treat infectious diseases for immunocompromised patients who are outpatients or hospitalized, infectious diseases imported from overseas, and HIV infectious diseases.
Our hospital has a well-equipped microbiology laboratory, and we can use the information obtained quickly to diagnose infectious diseases, and it is also useful for infection control such as hospital-related infections.
In our outpatient clinic, we provide vaccinations according to the needs of patients before traveling or when they visit, as well as other health consultations before and after traveling, and other consultations regarding sexual health.
From common infectious diseases to emerging infectious diseases
- A detailed medical history and physical examination are used to assess and, if necessary, test and treat.
- We also treat rare infections and undiagnosed cases. It would be helpful if you bring your previous test results and treatment details along with the referral letter.
Main diseases/treatments
There are no specific tests, but tests such as blood/urine tests, culture tests (general bacteria, acid-fast bacteria, fungi, etc.), cerebrospinal fluid/pleural and ascitic fluid tests, and imaging tests (simple X-ray, CT, MRI, echo) are recommended. , Diagnosis and treatment are performed appropriately according to the need.
Bacteremia, sepsis, meningitis, brain abscess, encephalitis, epidural abscess, peritonsillar abscess, malignant otitis externa, endophthalmitis, pneumonia, pulmonary abscess, empyema, infective endocarditis, mediastinitis, cholecystitis, cholangitis, liver abscess, infectious enteritis, appendicitis, pyelonephritis, prostatitis, pelvic inflammatory disease, suppurative spondylitis, septic arthritis, osteomyelitis, muscle abscess, cellulitis, necrotizing fasciitis, lymphadenitis, pressure ulcer infection, postoperative wound infection, catheter-related bloodstream infection, thrombophlebitis, febrile neutropenia, tuberculosis, syphilis, tetanus, nocardiosis, Japanese spotted fever, influenza, measles, rubella, chickenpox, shingles, cytomegalovirus infection, malaria, dengue fever, COVID-19, SFTS, rickettsial infection, etc.
Please refer to Travel Outpatient page.
Travel Outpatient pagePlease refer to the sexual health outpatient page.
Sexual Health Clinic9-valent human papillomavirus vaccine, pneumococcal vaccine, influenza vaccine, herpes zoster vaccine (both inactivated and live vaccines are available), measles vaccine, rubella vaccine, varicella vaccine, mumps vaccine, Japanese encephalitis vaccine, tetanus Vaccines, etc., are available.
Available vaccines and their vaccination schedulesTests such as blood/urine tests, culture tests (general bacteria, acid-fast bacteria, fungi, etc.), cerebrospinal fluid/pleural and ascitic fluid tests, and imaging tests (simple X-ray, CT, MRI, echo) are conducted to determine the need for diagnosis and treatment. We are doing it appropriately.
Medical record
Number of infectious disease consultations
| 2022 | 548 items |
| 2023 | 618 items |
| 2024 | 840 items |
clinical research
Notice Regarding Implementation of Clinical Research
Information disclosure date: February 15, 2017
For patients visiting the Infectious Disease
Currently, the Infectious Disease is conducting the following clinical research.
In this research, we will use the data (information) obtained from the patient's daily clinical practice.
If you would like to know more about the research plan or content, if you have any objections to the use of your data in this research, or if you have any other questions, please contact us at the contact information below. .
| Research subject name | Explanatory text (PDF) |
|---|---|
| A descriptive epidemiological study of the impact of COVID-19 infection from a hospital-affiliated nursery school into the hospital | |
| On the relationship between the environment and the isolation of Aspergillus from patient sputum in a prefabricated ward dedicated to COVID-19 | |
| A study to examine the effects of a mutant strain (VOC-202012/01) in novel coronavirus infections on clinical outcomes | |
| Cross-sectional study to understand the situation of new coronavirus infection in Kobe | |
| A cross-sectional study to understand the status of new virus infections in Kobe and a study on the accuracy of antibody tests | |
| A cross-sectional study to understand the status of novel virus infections in Kobe |
Multicenter retrospective study on the clinical background and course of capnocytophaga species infection
| Purpose of research | Clarifying the clinical picture of Capnocytophaga species infection, risk factors and treatment strategies by collecting and analyzing data obtained in normal medical care for patients in whom Capnocytophaga species was detected from blood and cerebrospinal fluid culture The purpose is to obtain knowledge that can be used as a reference when considering |
|---|---|
| Eligible patients | Patients who visited our department between January 1, 2007 and December 31, 2015, and for whom Capnocytophaga species were detected in blood and cerebrospinal fluid cultures. |
| Research period | From the date of approval by the clinical research ethics committee of our hospital to the end of March 2019 |
| Medical data to be used |
|
| Handling of Personal Information and Ethics | Research data may be provided to other facilities that are conducting joint research, but we will anonymize it by deleting information that can directly identify patients (names, medical record numbers, etc.), so our staff will Others cannot identify our patients. The results of this research may be presented at academic conferences and academic journals, but even in that case, the patient's privacy is protected because the patient's privacy is anonymized as described above. In addition, this research follows the guidelines set by the government and is being conducted with the review and approval of the clinical research ethics committee of our hospital. |
| Research Secretariat (point of contact for this research in general) | 自治医科大学付属さいたま医療センター 血液科 代表者名：鵜飼知嵩 住所：埼玉県さいたま市大宮区天沼町1-847 電話：048-647-2111 |
| Inquiries (our contact point) | 神戸市立医療センター中央市民病院 総合内科・感染症 研究責任医師：土井朝子 住所：神戸市中央区港島南町2丁目1-1 電話：078-302-4321 |
